Medicines Board to probe stem cell ferry plan
The IMB had already begun a probe into the provision of the treatment to multiple sclerosis sufferers from a Carrigaline clinic — but will now expand its inquiry.
Such stem cell treatment is not licensed here as experts say insufficient research has been completed on its effectiveness for MS sufferers.